Drugs / Actrapid insulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT01213563 | Jan 2009 → Sep 2010 | type 2 diabetes mellitus | Imperial College London | Terminated | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT07007130 Comparator | Jun 2025 → Mar 2026 overdue | — | Ain Shams University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Actrapid insulin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01213563 ↗ |
| Route | Other | “instilled intraperitoneally before closure” NCT07007130 ↗ |